WINSUNBIO
839729
HIGO
872351
DRIVE
838275
4
Shanghai Menon Animal Nutrition Technology
301156
5
Nanjing Railway New Technology
301016
CN Stock MarketDetailed Quotes
000822 Shandong Haihua
- 6.35
- +0.58+10.05%
Market Closed Apr 3 15:00 CST
5.68BMarket Cap144.32P/E (TTM)
6.35High5.50Low812.76KlotVolume5.70Open5.77Pre Close480.75MTurnover9.08%Turnover Ratio144.32P/E (Static)895.09MShares7.8152wk High1.09P/B5.68BFloat Cap4.5852wk Low6.35Limit Up895.09MShs Float20.08Historical High5.19Limit Down14.73%Amplitude2.08Historical Low0.10Dividend TTM5.92Avg Price378.85KlotAsk1.57%Div YieldTTM100Lot Size405.26KlotBid
Shandong Haihua Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -29.50%6.01B | -23.61%4.82B | -17.57%3.47B | -22.05%1.84B | -12.19%8.53B | -11.96%6.31B | -16.29%4.21B | 9.38%2.36B | 44.70%9.71B | 60.64%7.17B |
| Operating revenue | -29.50%6.01B | -23.61%4.82B | -17.57%3.47B | -22.05%1.84B | -12.19%8.53B | -11.96%6.31B | -16.29%4.21B | 9.38%2.36B | 44.70%9.71B | 60.64%7.17B |
| Other operating revenue | -13.68%91.34M | ---- | 2.74%56.07M | ---- | -4.51%105.82M | ---- | 1.62%54.58M | ---- | 4.68%110.81M | ---- |
| Total operating cost | -20.01%5.77B | -16.94%4.54B | -14.81%3.2B | -19.10%1.64B | -13.92%7.22B | -7.76%5.46B | -9.13%3.75B | 8.68%2.03B | 46.56%8.38B | 52.64%5.92B |
| Operating cost | -21.35%5.17B | -16.53%4.12B | -14.95%2.93B | -20.11%1.51B | -15.39%6.58B | -10.86%4.93B | -11.66%3.45B | 6.87%1.89B | 46.18%7.77B | 53.01%5.53B |
| Operating tax surcharges | -26.93%94.27M | -17.42%76.4M | -1.86%49.71M | -2.27%26.12M | -12.32%129.01M | -25.39%92.51M | -38.42%50.65M | -36.35%26.73M | 18.52%147.14M | 59.77%124M |
| Operating expense | -3.31%77.18M | -14.76%54.11M | -40.17%29.88M | -50.14%13.22M | 2.91%79.83M | 23.89%63.48M | 68.02%49.93M | 81.17%26.52M | 64.43%77.57M | 63.34%51.24M |
| Administration expense | 0.51%323.31M | -8.69%223.36M | -18.09%154.09M | 3.91%82.44M | 8.82%321.66M | 31.70%244.62M | 68.82%188.12M | 79.76%79.35M | 29.04%295.58M | 19.72%185.73M |
| Financial expense | 69.76%-2.3M | 84.44%-1.62M | 81.17%-1.53M | 98.31%-28K | -168.86%-7.6M | -132.30%-10.39M | -89.27%-8.13M | 26.62%-1.66M | -387.60%-2.83M | -2,421.89%-4.47M |
| -Interest expense (Financial expense) | 22.88%14.97M | 81.68%10.55M | 79.83%6.37M | 128.99%3.05M | -1.91%12.18M | -41.46%5.81M | -40.77%3.54M | 27.60%1.33M | 807.93%12.42M | 402.54%9.92M |
| -Interest Income (Financial expense) | -11.86%-22.65M | -5.57%-15.96M | 8.31%-9.23M | 3.98%-3.81M | -18.56%-20.25M | -28.62%-15.12M | -5.87%-10.06M | -13.99%-3.96M | -136.57%-17.08M | -134.10%-11.75M |
| Research and development | -8.24%106.7M | -51.11%68.58M | 36.43%30.83M | 22.90%9.83M | 25.69%116.28M | 329.07%140.28M | 262.56%22.59M | 28,901.20%7.99M | 3,591.73%92.52M | --32.69M |
| Credit Impairment Loss | 67.98%-6.13M | 57.81%-961.57K | 52.75%-915.11K | 73.14%-509.29K | -757.21%-19.13M | -122.15%-2.28M | -132.47%-1.94M | -34.73%-1.9M | 62.49%-2.23M | -438.53%-1.03M |
| Asset Impairment Loss | -3,131.63%-292.64M | -1,282.77%-104.42M | 43.26%-4.22M | -201.84%-2.51M | 71.11%-9.06M | 75.78%-7.55M | 9.71%-7.43M | 83.64%-832.48K | 59.79%-31.35M | 16.16%-31.18M |
| Other net revenue | -600.37%-196.52M | -207.56%-59.2M | 1,045.40%24.83M | 678.32%3.96M | -72.11%39.28M | -60.71%55.04M | -76.95%2.17M | -112.07%-685.29K | 259.90%140.83M | 67.99%140.1M |
| Fair value change income | 47,883.55%81.78M | 732.59%33.31M | 415.08%18.12M | ---- | -152.47%-171.14K | --4M | 855.17%3.52M | --563.42K | --326.14K | ---- |
| Invest income | -94.75%3.02M | -97.66%1.24M | -3.41%899.4K | -412.50%-1.07M | -54.60%57.51M | -58.95%53.04M | -83.65%931.2K | -54.95%341.19K | 1,831.81%126.67M | 2,065.57%129.21M |
| -Including: Investment income associates | 3,993.45%3.02M | 147.98%1.24M | -3.41%899.4K | -412.50%-1.07M | -98.69%73.82K | -132.56%-2.59M | -83.86%931.2K | -54.95%341.19K | -29.70%5.61M | 33.11%7.94M |
| Asset deal income | 34.28%7.35M | 39.75%7.35M | 39.72%7.35M | --7.35M | -39.37%5.47M | -6.10%5.26M | --5.26M | ---- | -91.43%9.02M | -94.60%5.6M |
| Other revenue | 116.95%10.1M | 66.79%4.28M | 96.77%3.6M | -38.27%702.79K | -87.88%4.65M | -93.15%2.57M | -85.25%1.83M | -90.03%1.14M | 244.28%38.39M | 265.36%37.49M |
| Operating profit | -96.70%44.59M | -75.44%220.87M | -34.95%301.49M | -38.41%208.58M | -8.09%1.35B | -34.92%899.31M | -49.25%463.48M | 11.41%338.64M | 42.53%1.47B | 108.40%1.38B |
| Add:Non operating Income | 19.44%6.95M | -1.76%5M | -35.07%2.72M | 122.33%804.27K | 142.41%5.82M | 147.66%5.09M | 295.59%4.19M | -17.55%361.75K | -9.69%2.4M | 3.91%2.06M |
| Less:Non operating expense | -59.36%3.04M | -53.76%2.24M | 38.14%1.69M | 628.90%537.5K | -80.06%7.48M | -82.32%4.84M | -95.37%1.22M | -96.60%73.74K | 383.99%37.51M | 2,799.77%27.39M |
| Total profit | -96.41%48.49M | -75.14%223.64M | -35.14%302.52M | -38.38%208.85M | -5.96%1.35B | -33.68%899.56M | -47.46%466.45M | 12.14%338.93M | 39.82%1.44B | 104.26%1.36B |
| Less:Income tax cost | -96.97%9.28M | -77.86%51.86M | -34.15%78.17M | -46.42%53.22M | -6.35%306.17M | -23.87%234.27M | -47.39%118.71M | 25.77%99.33M | 18.72%326.94M | 82.78%307.71M |
| Net profit | -96.24%39.22M | -74.18%171.78M | -35.48%224.35M | -35.05%155.63M | -5.84%1.04B | -36.56%665.29M | -47.49%347.74M | 7.32%239.6M | 47.55%1.11B | 111.56%1.05B |
| Net profit from continuing operation | -96.24%39.22M | -74.18%171.78M | -35.48%224.35M | -35.05%155.63M | -5.84%1.04B | -36.56%665.29M | -47.49%347.74M | 7.32%239.6M | 47.55%1.11B | 111.56%1.05B |
| Less:Minority Profit | 100.15%214.62 | 100.15%214.62 | 100.16%214.62 | ---- | -125.57%-140.42K | -131.00%-140.42K | -139.17%-138.43K | -13.28%143.44K | -22.38%549.23K | -14.67%452.96K |
| Net profit of parent company owners | -96.24%39.22M | -74.19%171.78M | -35.51%224.35M | -35.01%155.63M | -5.78%1.04B | -36.52%665.43M | -47.44%347.88M | 7.33%239.46M | 47.61%1.11B | 111.69%1.05B |
| Earning per share | ||||||||||
| Basic earning per share | -96.58%0.04 | -74.32%0.19 | -35.90%0.25 | -37.04%0.17 | -5.65%1.17 | -36.75%0.74 | -47.30%0.39 | 8.00%0.27 | 47.62%1.24 | 112.73%1.17 |
| Diluted earning per share | -96.58%0.04 | -74.32%0.19 | -35.90%0.25 | -37.04%0.17 | -5.65%1.17 | -36.75%0.74 | -47.30%0.39 | 8.00%0.27 | 47.62%1.24 | 112.73%1.17 |
| Other composite income | 16.8M | -4.05K | 4.64M | 22.02K | 77.09%-1.06K | 99.26%-1.06K | ||||
| Other composite income of parent company owners | --16.8M | ---4.05K | --4.64M | --22.02K | ---- | ---- | ---- | ---- | 77.09%-1.06K | 99.26%-1.06K |
| Total composite income | -94.63%56.02M | -74.18%171.77M | -34.15%228.99M | -35.04%155.65M | -5.84%1.04B | -36.56%665.29M | -47.49%347.74M | 7.32%239.6M | 47.55%1.11B | 111.62%1.05B |
| Total composite income of parent company owners | -94.63%56.02M | -74.19%171.77M | -34.18%228.99M | -35.00%155.65M | -5.78%1.04B | -36.52%665.43M | -47.44%347.88M | 7.33%239.46M | 47.61%1.11B | 111.75%1.05B |
| Total composite income of minority owners | 100.15%214.62 | 100.15%214.62 | 100.16%214.62 | ---- | -125.57%-140.42K | -131.00%-140.42K | -139.17%-138.43K | -13.28%143.44K | -22.38%549.23K | -14.67%452.96K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | China Audit Asia Pacific Accounting Firm (Special General Partnership) | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.